Cyclophosphamide, epirubicin, and fluorouracil (CEF) regimen for breast cancer

Alexandra Moller, Dominic Solimando, James Waddell

Research output: Contribution to journalReview article

Abstract

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases. Questions or suggestions for topics should be addressed to Dominic A. Solimando, Jr., President, Oncology Pharmacy Services, Inc., 4201 Wilson Boulevard #110-545, Arlington, VA 22203, e-mail: OncRxSvc@comcast.net; or J. Aubrey Waddell, Professor, University of Tennessee College of Pharmacy; Oncology Pharmacist, Pharmacy Department, Blount Memorial Hospital, 907 E. Lamar Alexander Parkway, Maryville, TN 37804, email: waddfour@charter.net.

Original languageEnglish (US)
Pages (from-to)683-689
Number of pages7
JournalHospital Pharmacy
Volume47
Issue number9
DOIs
StatePublished - Sep 1 2012

Fingerprint

Epirubicin
Oncology
Pharmacists
Fluorouracil
Cyclophosphamide
Breast Neoplasms
Pharmaceutical Services
Chemotherapy
Poisons
Highway systems
Postal Service
Antineoplastic Agents
Drug Therapy
Neoplasms
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacy
  • Pharmacology
  • Pharmacology (medical)

Cite this

Cyclophosphamide, epirubicin, and fluorouracil (CEF) regimen for breast cancer. / Moller, Alexandra; Solimando, Dominic; Waddell, James.

In: Hospital Pharmacy, Vol. 47, No. 9, 01.09.2012, p. 683-689.

Research output: Contribution to journalReview article

Moller, Alexandra ; Solimando, Dominic ; Waddell, James. / Cyclophosphamide, epirubicin, and fluorouracil (CEF) regimen for breast cancer. In: Hospital Pharmacy. 2012 ; Vol. 47, No. 9. pp. 683-689.
@article{dcce5c4b30ed4c71824e547de2c18972,
title = "Cyclophosphamide, epirubicin, and fluorouracil (CEF) regimen for breast cancer",
abstract = "The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases. Questions or suggestions for topics should be addressed to Dominic A. Solimando, Jr., President, Oncology Pharmacy Services, Inc., 4201 Wilson Boulevard #110-545, Arlington, VA 22203, e-mail: OncRxSvc@comcast.net; or J. Aubrey Waddell, Professor, University of Tennessee College of Pharmacy; Oncology Pharmacist, Pharmacy Department, Blount Memorial Hospital, 907 E. Lamar Alexander Parkway, Maryville, TN 37804, email: waddfour@charter.net.",
author = "Alexandra Moller and Dominic Solimando and James Waddell",
year = "2012",
month = "9",
day = "1",
doi = "10.1310/hpj4709-683",
language = "English (US)",
volume = "47",
pages = "683--689",
journal = "Hospital Pharmacy",
issn = "0018-5787",
publisher = "Facts and Comparisons",
number = "9",

}

TY - JOUR

T1 - Cyclophosphamide, epirubicin, and fluorouracil (CEF) regimen for breast cancer

AU - Moller, Alexandra

AU - Solimando, Dominic

AU - Waddell, James

PY - 2012/9/1

Y1 - 2012/9/1

N2 - The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases. Questions or suggestions for topics should be addressed to Dominic A. Solimando, Jr., President, Oncology Pharmacy Services, Inc., 4201 Wilson Boulevard #110-545, Arlington, VA 22203, e-mail: OncRxSvc@comcast.net; or J. Aubrey Waddell, Professor, University of Tennessee College of Pharmacy; Oncology Pharmacist, Pharmacy Department, Blount Memorial Hospital, 907 E. Lamar Alexander Parkway, Maryville, TN 37804, email: waddfour@charter.net.

AB - The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases. Questions or suggestions for topics should be addressed to Dominic A. Solimando, Jr., President, Oncology Pharmacy Services, Inc., 4201 Wilson Boulevard #110-545, Arlington, VA 22203, e-mail: OncRxSvc@comcast.net; or J. Aubrey Waddell, Professor, University of Tennessee College of Pharmacy; Oncology Pharmacist, Pharmacy Department, Blount Memorial Hospital, 907 E. Lamar Alexander Parkway, Maryville, TN 37804, email: waddfour@charter.net.

UR - http://www.scopus.com/inward/record.url?scp=84867315074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867315074&partnerID=8YFLogxK

U2 - 10.1310/hpj4709-683

DO - 10.1310/hpj4709-683

M3 - Review article

VL - 47

SP - 683

EP - 689

JO - Hospital Pharmacy

JF - Hospital Pharmacy

SN - 0018-5787

IS - 9

ER -